Device / Technology News

RSS

Hemova device can reduce risk of infection, clotting and vessel narrowing in dialysis patients

Johns Hopkins University graduate students have invented a device to reduce the risk of infection, clotting and narrowing of the blood vessels in patients who need blood-cleansing dialysis because of kidney failure.

30 Jun 2011

Rapid, accurate test differentiates between bacterial and viral infections

Scientists are reporting development and successful testing of a rapid and accurate test to tell the difference between bacterial and viral infections. Those common afflictions often have similar symptoms but vastly different treatments - antibiotics work for bacterial infections but not for viruses. The report appears in ACS' journal Analytical Chemistry.

30 Jun 2011

NLST: CT scans more effective in reducing lung cancer death rates

The National Lung Screening Trial (NLST) is the first scientific study that provides clear evidence that CT screening significantly reduces the death rate due to lung cancer.

30 Jun 2011

Pregenen, Cellectis partner to develop meganucleases

Cellectis, the French genome engineering specialist, announced today the signing of a collaboration agreement with Pregenen, an American biotechnology start-up company dedicated to the creation of innovative tools for genome engineering.

30 Jun 2011

Video consultation initiative great opportunity for patients and GPs

With the new video consultation MBS items being available from 1 July 2011, the Royal Australian College of General Practitioners (RACGP) is committed to supporting the profession during the telehealth rollout and highlights the value of the GP in this healthcare model.

29 Jun 2011

Novel use of duct tape in infection prevention saves $110,000 annually

The Trinity Infection Prevention team from Iowa/Illinois Trinity Medical Center has come up with the novel idea of using duct tape to reduce infections and save up to $110,000. For this they received the Blue Ribbon Abstract Award. They presented their work, “The Red Box Strategy: An Innovative Method to Improve Isolation Precaution Compliance and Reduce Costs” which received the designation at the Association for Professionals in Infection Control and Epidemiology's 2011 Annual Conference and International Meeting June27-29 in Baltimore.

29 Jun 2011

Cayenne Medical introduces second generation device for treatment of traumatic meniscal tears

Cayenne Medical, Inc., a private sports medicine device company, announces the launch of CrossFix II Meniscal Repair System, its second generation device for treatment of traumatic meniscal tears.

29 Jun 2011

NEC's MultiSync MD301C4 medical diagnostic display receives FDA 510(k) marketing clearance

NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.

29 Jun 2011

DiagnoCure, Signal Genetics enter commercialization collaboration for Previstage GCC Colorectal Cancer Staging Test

Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc., a life sciences company that develops and commercializes high-value cancer diagnostic tests, today announced a collaboration arrangement valued at US$13.3M over the first five years.

29 Jun 2011

New prostate cancer drugs bring cost of care into spotlight

Meanwhile, results from a three-decade Swedish study found that women who have mammograms have a lower death rate from breast cancer — a finding that some say may ease recent controversies around the screening procedure.

29 Jun 2011

FamilyCord launches advanced cord tissue stem cell processing and storage

FamilyCord, one of the nation's leading cord blood banks, today announced their latest contribution to the advancement of the umbilical cord blood and tissue storage industry: CordTissuePlus.

29 Jun 2011

DMI completes rHEALTH sensor reduced-gravity experiments for NASA FAST program

In September 2010, the DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments on its rHEALTH sensor for the NASA Facilitated Access to the Space Environment for Technology (FAST) program. NASA recently followed that experiment with a $190,000 contract to DMI to analyze data from the parabolic flights.

29 Jun 2011

Improved design and user behavior can decrease stepladder accidents

Stepladders, a household product used by thousands of people every day, are a surprisingly common cause of injury. In 2009, more than 187,000 Americans visited the hospital after sustaining stepladder injuries, many of which resulted from a fall. A recent human factors/ergonomics study explores how improved design and user behavior can decrease the likelihood of future accidents.

29 Jun 2011

Medtronic launches mobile application for implantable cardiac devices

Medtronic, Inc. today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care shifts care delivery from outpatient to home, Medtronic is leading the implantable cardiac device industry by offering cutting-edge technology designed to give physicians greater flexibility in monitoring patient data.

From Medtronic 29 Jun 2011

U.Va. and Epsilon partner to provide commercial version of computer-based diabetes simulation tool

A computer-based diabetes simulation tool developed by University of Virginia researchers is now commercially available, thanks to a partnership with the Charlottesville-based medical research firm The Epsilon Group. The simulator is the only protocol that has been accepted by the U.S. Food and Drug Administration as an alternative to animal testing of Type 1 diabetes control strategies.

29 Jun 2011

Start of clinical validation study of Down’s syndrome diagnostic test

In conjunction with several Central European prenatal centers, scientists at GATC Biotech AG and LifeCodexx AG have begun the clinical validation study of a non-invasive, prenatal diagnostic test based on next generation sequencing.

28 Jun 2011

IOTA NanoSolutions secures funding for commercialisation of ContraSol technology

IOTA NanoSolutions Limited, a specialist formulation company, is pleased to announce today that it has completed a financing round to support the commercialisation of its proprietary nanodispersion formation technology, ContraSol™. New investor, QIB(UK) Plc joins Unilever Ventures Limited (UV) in this financing round.

28 Jun 2011

Conventional Estrogen Receptor measurement methods may result in 10-20% false negative rate

A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology.

28 Jun 2011

Screening with mammography reduces deaths from breast cancer

Results from the longest running breast screening trial show that screening with mammography reduces the number of deaths from breast cancer.

28 Jun 2011

454 Life Sciences launches new GS FLX+ System for high-throughput sequencing

454 Life Sciences, a Roche Company, announced today the launch and immediate availability of the new GS FLX+ System, an instrument capable of generating extra-long sequencing reads up to 1,000 by in length.

28 Jun 2011

Device / Technology News

Hemova device can reduce risk of infection, clotting and vessel narrowing in dialysis patients

Rapid, accurate test differentiates between bacterial and viral infections

NLST: CT scans more effective in reducing lung cancer death rates

Pregenen, Cellectis partner to develop meganucleases

Video consultation initiative great opportunity for patients and GPs

Novel use of duct tape in infection prevention saves $110,000 annually

Cayenne Medical introduces second generation device for treatment of traumatic meniscal tears

NEC's MultiSync MD301C4 medical diagnostic display receives FDA 510(k) marketing clearance

DiagnoCure, Signal Genetics enter commercialization collaboration for Previstage GCC Colorectal Cancer Staging Test

New prostate cancer drugs bring cost of care into spotlight

FamilyCord launches advanced cord tissue stem cell processing and storage

DMI completes rHEALTH sensor reduced-gravity experiments for NASA FAST program

Improved design and user behavior can decrease stepladder accidents

Medtronic launches mobile application for implantable cardiac devices

U.Va. and Epsilon partner to provide commercial version of computer-based diabetes simulation tool

Start of clinical validation study of Down’s syndrome diagnostic test

IOTA NanoSolutions secures funding for commercialisation of ContraSol technology

Conventional Estrogen Receptor measurement methods may result in 10-20% false negative rate

Screening with mammography reduces deaths from breast cancer

454 Life Sciences launches new GS FLX+ System for high-throughput sequencing

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News